Try it
Biochemistry · Lipid metabolism: fibrates and PPAR-alpha
Sample itemA man with triglycerides of 800 mg/dL and low HDL cholesterol is started on fenofibrate. Which receptor does the drug activate to lower triglycerides?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Peroxisome proliferator-activated receptor alpha
Fibrates activate PPAR-alpha, which increases lipoprotein lipase expression and fatty acid oxidation and reduces apolipoprotein C-III, so triglyceride-rich lipoproteins are cleared faster. HDL rises modestly. Thiazolidinediones act through PPAR-gamma.
Option by option
A. Peroxisome proliferator-activated receptor alpha (correct)
Correct. PPAR-alpha activation increases lipoprotein lipase and fatty acid oxidation and lowers triglycerides.
B. Farnesoid X receptor
Farnesoid X receptor is activated by bile acids and regulates bile acid synthesis, not the fibrate target.
C. Peroxisome proliferator-activated receptor gamma
PPAR-gamma is the target of thiazolidinediones and mainly improves insulin sensitivity.
D. Liver X receptor
Liver X receptor responds to oxysterols and regulates cholesterol efflux, but it is not the fibrate target.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…